SynthesisToxins2022

Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine.

Damiana Scuteri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.